These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11902503)

  • 1. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention.
    Chan TA
    Lancet Oncol; 2002 Mar; 3(3):166-74. PubMed ID: 11902503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.
    Rigas B; Shiff SJ
    Med Hypotheses; 2000 Feb; 54(2):210-5. PubMed ID: 10790755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive effects of NSAIDs against colorectal cancer: regulation of apoptosis and mitosis by COX-1 and COX-2.
    Watson AJ
    Histol Histopathol; 1998 Apr; 13(2):591-7. PubMed ID: 9589912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.
    Farrugia G; Balzan R
    Oxid Med Cell Longev; 2013; 2013():504230. PubMed ID: 23983899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.
    Yao R; Rioux N; Castonguay A; You M
    Exp Lung Res; 2000 Dec; 26(8):731-42. PubMed ID: 11195467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclo-oxygenase and colon cancer: clues to the aspirin effect?
    Gustafson-Svärd C; Lilja I; Hallböök O; Sjödahl R
    Ann Med; 1997 Jun; 29(3):247-52. PubMed ID: 9240630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
    Reddy BS
    Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenases and colon cancer.
    Kawai N; Tsujii M; Tsuji S
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():187-96. PubMed ID: 12432918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
    Elder DJ; Halton DE; Hague A; Paraskeva C
    Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs and chemoprevention.
    Rao CV; Reddy BS
    Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer.
    Stockbrügger RW
    Eur J Cancer Prev; 1999 Dec; 8 Suppl 1():S21-5. PubMed ID: 10772414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
    Hung WC
    Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: COX-2, prostanoids and colon cancer.
    Ota S; Bamba H; Kato A; Kawamoto C; Yoshida Y; Fujiwara K
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():102-6. PubMed ID: 11966530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
    Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
    Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.